|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rosell R and Karachaliou N: Lung cancer:
Maintenance therapy and precision medicine in NSCLC. Nat Rev Clin
Oncol. 10:549–550. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wood SL, Pernemalm M, Crosbie PA and
Whetton AD: The role of the tumor-microenvironment in lung
cancer-metastasis and its relationship to potential therapeutic
targets. Cancer Treat Rev. 40:558–566. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Xiang JF, Yin QF, Chen T, Zhang Y, Zhang
XO, Wu Z, Zhang S, Wang HB, Ge J, Lu X, et al: Human colorectal
cancer-specific CCAT1-L lncRNA regulates long-range chromatin
interactions at the MYC locus. Cell Res. 24:513–531. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhu HQ, Zhou X, Chang H, Li HG, Liu FF, Ma
CQ and Lu J: Aberrant expression of CCAT1 regulated by c-Myc
predicts the prognosis of hepatocellular carcinoma. Asian Pac J
Cancer Prev. 16:5181–5185. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang F, Xie C, Zhao W, Deng Z, Yang H and
Fang Q: Long non-coding RNA CARLo-5 expression is associated with
disease progression and predicts outcome in hepatocellular
carcinoma patients. Clin Exp Med. 17:33–43. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yang F, Xue X, Bi J, Zheng L, Zhi K, Gu Y
and Fang G: Long noncoding RNA CCAT1, which could be activated by
c-Myc, promotes the progression of gastric carcinoma. J Cancer Res
Clin Oncol. 139:437–445. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kim T, Cui R, Jeon YJ, Lee JH, Lee JH, Sim
H, Park JK, Fadda P, Tili E, Nakanishi H, et al: Long-range
interaction and correlation between MYC enhancer and oncogenic long
noncoding RNA CARLo-5. Proc Natl Acad Sci USA. 111:4173–4178. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Beermann J, Piccoli MT, Viereck J and Thum
T: Non-coding RNAs in development and disease: Background,
mechanisms, and therapeutic approaches. Physiol Rev. 96:1297–1325.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang YR, Zang SZ, Zhong CL, Li YX, Zhao SS
and Feng XJ: Increased expression of the lncRNA PVT1 promotes
tumorigenesis in non-small cell lung cancer. Int J Clin Exp Pathol.
7:6929–6935. 2014.PubMed/NCBI
|
|
12
|
Nie FQ, Sun M, Yang JS, Xie M, Xu TP, Xia
R, Liu YW, Liu XH, Zhang EB, Lu KH and Shu YQ: Long noncoding RNA
ANRIL promotes non-small cell lung cancer cell proliferation and
inhibits apoptosis by silencing KLF2 and P21 expression. Mol Cancer
Ther. 14:268–277. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nie W, Ge HJ, Yang XQ, Sun X, Huang H, Tao
X, Chen WS and Li B: LncRNA-UCA1 exerts oncogenic functions in
non-small cell lung cancer by targeting miR-193a-3p. Cancer Lett.
371:99–106. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shen L, Chen L, Wang Y, Jiang X, Xia H and
Zhuang Z: Long noncoding RNA MALAT1 promotes brain metastasis by
inducing epithelial-mesenchymal transition in lung cancer. J
Neurooncol. 121:101–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang G, Chen H and Liu J: The long
noncoding RNA LINC01207 promotes proliferation of lung
adenocarcinoma. Am J Cancer Res. 5:3162–3173. 2015.PubMed/NCBI
|
|
16
|
Wu Y, Liu H, Shi X, Yao Y, Yang W and Song
Y: The long non-coding RNA HNF1A-AS1 regulates proliferation and
metastasis in lung adenocarcinoma. Oncotarget. 6:9160–9172.
2015.PubMed/NCBI
|
|
17
|
Alaiyan B, Ilyayev N, Stojadinovic A,
Izadjoo M, Roistacher M, Pavlov V, Tzivin V, Halle D, Pan H, Trink
B, et al: Differential expression of colon cancer associated
transcript1 (CCAT1) along the colonic adenoma-carcinoma sequence.
BMC Cancer. 13:1962013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen J, Zhang K, Song H, Wang R, Chu X and
Chen L: Long noncoding RNA CCAT1 acts as an oncogene and promotes
chemoresistance in docetaxel-resistant lung adenocarcinoma cells.
Oncotarget. 7:62474–62489. 2016.PubMed/NCBI
|
|
19
|
Luo J, Tang L, Zhang J, Ni J, Zhang HP,
Zhang L, Xu JF and Zheng D: Long non-coding RNA CARLo-5 is a
negative prognostic factor and exhibits tumor pro-oncogenic
activity in non-small cell lung cancer. Tumour Biol.
35:11541–11549. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hampton KK and Craven RJ: Pathways driving
the endocytosis of mutant and wild-type EGFR in cancer.
Oncoscience. 1:504–512. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rolfo C, Giovannetti E, Hong DS, Bivona T,
Raez LE, Bronte G, Buffoni L, Reguart N, Santos ES, Germonpre P, et
al: Novel therapeutic strategies for patients with NSCLC that do
not respond to treatment with EGFR inhibitors. Cancer Treat Rev.
40:990–1004. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sequist LV, Waltman BA, Dias-Santagata D,
Digumarthy S, Turke AB, Fidias P, Bergethon K, Shaw AT, Gettinger
S, Cosper AK, et al: Genotypic and histological evolution of lung
cancers acquiring resistance to EGFR inhibitors. Sci Transl Med.
3:75ra262011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ma MZ, Chu BF, Zhang Y, Weng MZ, Qin YY,
Gong W and Quan ZW: Long non-coding RNA CCAT1 promotes gallbladder
cancer development via negative modulation of miRNA-218-5p. Cell
Death Dis. 6:e15832015. View Article : Google Scholar : PubMed/NCBI
|
